Loved watching Lorde full on WWT.

Out of touch senior moment watching Glasto : .When you think With British Sign Language are a new band.

Sporting the McLipworth tartan today .Full disclosure I’m not Scottish but lived here for 39 years

EU-ADVANTAGE study . Real life clinical remission more likely to be acheived with Dupilumab vs Omalizumab/Mepolizumab/Benralizumab in refractory severe asthma

Stunning results from EVEREST trial at EAACI. First ever prospective H2H of biologics in pts with Asthma and CRSwNP.Sig and clinically relevant superiority for Dupilumab >Omalizumab on upper/lower airway outcomes .Nuff said .

My fellow Dr Bobby Greig looking resplendent in full tartan at EAACI in Glasgow

Come along to hear my talk on small airways effects of Dupilumab vs Placebo from the phase 4 VESTIGE trial in the Innovation Hub at SEC at EAACI in Glasgow at 1609.

If you are at EAACI in Glasgow then please do come along on Monday 16 June to the Plenary Session in Lomond Auditorium at SEC . 0900-0930 .Head-to-Head Comparison of Biologics in Asthma: What Have We Learned?. Key slides also in May issue Allergy :.

RT @ProfJDChalmers: Join me on tuesday for a webinar on the ERS Respiratory Channel!.Science Communication including.- Writing a paper for….

Today I reached a key research milestone when my h index hit the 100 mark. Thanks to all of my fellows and the team who put in the hard yards and made this possible . Onwards and upwards now ….

Itepekimab in COPD (AERIFY 1/2) .Primary EP of AER at wk 52 was met in AERIFY-1 as 27% reduction with Itep Q2wk and 21% with Itep Q4wk .But not in AERIFY-2 with 2% and 12% reductions respectively . Need absolute and % AER to make more sense of data.

Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP) via @YouTube. Here is a non promotional educational video I made for the forthcoming Yorkshire Annual Asthma Conference.

At Dutch National ENT Congress . Trying my best not to look too much like @elonmusk salute during my talk today l